Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenues:
Products	$ 19,828	$ 15,527
Revenue from services	1,970	3,092
Revenue from transfer of intellectual property	476	12,757
Total revenues	22,274	31,376
Costs and expenses:
Costs of revenues	12,391	11,757
Selling, general and administrative	13,812	12,424
Research and development	20,994	9,910
Contingent consideration	2,610	1,344
Amortization of intangible assets	2,744	2,714
Total costs and expenses	52,551	38,149
Operating loss	(30,277)	(6,773)
Other income and (expense), net:
Interest income	40	59
Interest expense	(3,486)	(2,897)
Fair value changes of derivative instruments, net	(10,515)	(23,549)
Other income (expense), net	1,817	2,331
Other income and (expense), net	(12,144)	(24,056)
Loss before income taxes and investment losses	(42,421)	(30,829)
Income tax benefit (provision)	(614)	(43)
Loss before investment losses	(43,035)	(30,872)
Loss from investments in investees	(2,056)	(3,890)
Net loss	(45,091)	(34,762)
Less: Net loss attributable to noncontrolling interests	(540)	(547)
Net loss attributable to common shareholders before preferred stock dividend	(44,551)	(34,215)
Preferred stock dividend	0	(420)
Net loss attributable to common shareholders	$ (44,551)	$ (34,635)
Net loss per share (usd per share)	$ (0.11)	$ (0.11)
Weighted average number of common shares outstanding, basic and diluted	412,909,809	312,932,561